Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: A CATIE analysis

Schizophrenia Research

Volumn 150, Issue 2-3, 2013, Pages 339-342

  Rabinowitz, Jonathan ^a   Berardo, Carmen Galani ^b   Bugarski Kirola, Dragana ^b   Marder, Stephen ^c  

^a BAR ILAN UNIVERSITY   (Israel)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Burden; Functional health; Prominent negative; Prominent positive; Quality of life; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CAREGIVER SUPPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILY STRESS; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 12; SYMPTOMATOLOGY; WELLBEING;

BURDEN; FUNCTIONAL HEALTH; PROMINENT NEGATIVE; PROMINENT POSITIVE; QUALITY OF LIFE; SCHIZOPHRENIA;

CLINICAL TRIALS AS TOPIC; FAMILY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84886238591     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.07.014     Document Type: Article

References (14)

1. Alonso J., Croudace T., Brown J., Gasquet I., Knapp M.R., Suarez D., Novick D. Health-related quality of life (HRQL) and continuous antipsychotic treatment: 3-year results from the Schizophrenia Health Outcomes (SOHO) study. Value Health 2009, 12(4):536-543.
2. Bobes J., Arango C., Garcia-Garcia M., Rejas J., Group C.S.C. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J. Clin. Psychiatry 2010, 71(3):280-286.
3. Brazier J.E., Roberts J. The estimation of a preference-based measure of health from the SF-12. Med. Care 2004, 42(9):851-859.
4. Fenton W.S., McGlashan T.H. Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Arch. Gen. Psychiatry 1991, 48(11):978-986.
5. Harvey P.D., Heaton R.K., Carpenter W.T., Green M.F., Gold J.M., Schoenbaum M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophr. Res. 2012, 140(1-3):1-8.
6. Kane J. Commentary: consensus statement on negative symptoms. Schizophr. Bull. 2006, 32(2):223-224.
7. Kinon B.J., Noordsy D.L., Liu-Seifert H., Gulliver A.H., Ascher-Svanum H., Kollack-Walker S. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning. J. Clin. Psychopharmacol. 2006, 26(5):453-461.
8. Kirkpatrick B., Buchanan R.W. Anhedonia and the deficit syndrome of schizophrenia. Psychiatry Res. 1990, 31:25-30.
9. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32(2):214-219.
10. Lenert L.A., Sturley A.P., Rapaport M.H., Chavez S., Mohr P.E., Rupnow M. Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores. Schizophr. Res. 2004, 71(1):155-165.
11. Lenert L.A., Sturley A.E., Rapaport M., Chavez S., Mohr P.E., Rupnow M. Corrigendum to Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores. Schizophr. Res. 2005, 80:135-136.
12. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., Hsiao J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005, 353(12):1209-1223.
13. Novick D., Haro J.M., Suarez D., Vieta E., Naber D. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study. Schizophr. Res. 2009, 108(1-3):223-230.
14. Rabinowitz J., Levine S.Z., Garibaldi G., Bugarski-Kirola D., Berardo C.G., Kapur S. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr. Res. 2012, 137(1-3):147-150.